Vaccination of Colorectal Cancer Patients with Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax) Induces Immune Responses which Correlate with Disease Control: A Phase I/II Trial
Year: 2006
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
Institutions: Oxford BioMedica (United Kingdom), The Christie Hospital
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2107106395
